By Josh Beckerman Timber Pharmaceuticals shares were recently down 69% to 45 cents following the company's chapter 11 filing and a delisting notice from NYSE.
Timber Pharmaceuticals (NYSE:TMBR – Get Free Report) and Relmada Therapeutics (NASDAQ:RLMD – Get Free Report) are both small-cap medical companies, but which is the better investment? We will compare the two businesses based on the strength of their earnings, risk, analyst recommendations, institutional ownership, dividends, valuation and profitability. Analyst Recommendations This is a summary of […]
Canada's worst-ever spring wildfire season has forced its forestry industry to shutter sawmills, driving up lumber prices and setting production back for months just as housing construction has slowed due to higher costs and a tight labour market.
The Australian government on Tuesday welcomed a defence cooperation agreement between its closest neighbour Papua New Guinea (PNG) and the U.S. aimed at bolstering regional security amid China's plans to increase influence in the Pacific.
Lowe's Cos Inc cut its annual sales and profit forecasts on Tuesday, joining larger rival Home Depot in highlighting waning demand for home improvement tools with sticky inflation forcing consumers to cut back on discretionary spending.